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ABSTRACT
￿
Human blood platelets, which are highly motile cells essential for the maintenance
of hemostasis, contain large quantities of actin and other contractile proteins . We have
previously introduced a method (Lucas, R. C., T. C. Detwiler, andA . Stracher, J . Cell Biol ., 1976,
70(2, Pt . 2) :259 a) for the quantitative recovery of the platelets' cytoskeleton using a solution
containing 1% Triton X-100 and 10 mM EGTA . This cytoskeleton contains most of the platelets'
actin, actin-binding protein (ABP, subunit molecular weight = 260,000), and a 105,000-dalton
protein. Negative staining of this Triton-insoluble residue on an EM grid shows it to consist of
branched cables of actin filaments aligned in parallel .
When this cytoskeletal structure is dissolved in high-salt solutions, the actin and ABP
dissociate and can subsequently be separated . Here we will present simple and rapid methods
for the individual purifications of platelet actin and platelet ABP.
When purified actin and ABP are recombined in vitro, they are shown to be both necessary
and sufficient for the reformation of the cytoskeletal complex . The reformed structure is
visualized as a complex array of fibers, which at the EM level are seen to be bundles of actin
filaments . The reformation of the cytoskeleton requires only that the actin be in thefilamentous
form-no accessory proteins, chelating agents, divalent cations, or energy sources are necessary .
In vivo, however, the state of assembly of the platelets' cytoskeleton appears to be under the
control of the intracellular concentration of free calcium . Under conditions where proteolysis
is inhibited and EGTA is omitted from the Triton-solubiIization step, no cytoskeleton can be
isolated . The ability of Ca
12 to control the assembly and disassembly of the platelets' cyto-
skeleton provides a mechanism for cytoskeletal involvement in shape change and pseudopod
formation during platelet activation .
Human blood platelets are anucleate, discoid cells 2-3 gm in
diameter. Under appropriate physiological stimuli, platelets
undergo abrupt morphological changes to prevent bleeding
from damaged blood vessels ; the platelets change in shape
from disks to spheres, send out long, slender filopodia, cen-
tralize their organelles, secrete the contents of their granules,
aggregate with one another to form a hemostatic plug, and
retract these aggregates (56). Contractile proteins have been
implicated in most of these processes (1) .
Crude actomyosin was originally isolated from platelets by
Bettex-Galland and Liischer in 1959 (4, 5) and was found to
have many properties similar to those of actomyosins from
other sources, including the ability to be dissociated into an
actinlike and a myosinlike component . Filaments of these
proteins have been difficult to identify and localize in thin
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sections of intact resting platelets because of the dense fibro-
granular material filling the cytoplasmic matrix. However,
electron micrographs of resting and stimulated platelets, after
osmotic shock or glycerination to rarify the cytoplasm, show
filaments distributed throughout the cytoplasm and filopodia
(3, 57) . Their ability to bind heavy meromyosin (HMM) iden-
tifies them as actin-containing microfilaments . The greater
ratio of actin:myosin in nonmuscle cells than in muscle cells
implies that actin in nonmuscle cells has more than just a
contractile role, e.g ., a cytoskeletal role .
In 1976, we introduced a procedure for the direct isolation,
from human blood platelets, of a "cytoskeletal complex" that
contained most of the platelets' actin and a high molecular
weight (260,000 dalton) actin-binding protein (ABP) (26) .
Platelet ABP was originally named on the basis of its similar-
201ities to the high molecular weight protein isolated from rabbit
alveolar macrophages by Hartwig and Stossel (17, 47) . Kane
(22, 23) also described ahighmolecular weight (220,000 dalton)
protein involved in the cross-linking of actin in sea urchin egg
extracts into a solid birefringent gel. Subsequently, other high
molecular weight actin-binding or gelation proteins have been
identified in various nonmuscle cells (6, 11, 12, 19, 21, 31, 33,
43, 44, 49, 55) . These proteins may or may not be similar to
filamin isolated from smooth muscle and skeletal muscle
sources (2, 45, 52, 54) . ABPs and filamins from some of these
sources show antibody cross-reactivity (14, 52, 54) and similar
amino acid compositions (44, 52) . In addition to these high
molecular weight proteins, lower molecular weight actin cross-
linking proteins have been purified from Acanthamoeba (29,
30) and Ehrlich ascites tumor cells (32) .
In this paper we describe unique purification schemes for
both ABP and actin from the platelet cytoskeleton whose in
vitro recombination results in the formation of a structure
remarkably similar to the platelets' native cytoskeleton, as
visualized by negative staining . The reassembly of the platelet
cytoskeleton from its purified components appears only to be
affected by increasing ionic strength whereas, in the platelet
lysates, increasing Ca
+2 is found to disrupt the cytoskeleton .
The regulation of the interaction between ABP and actin, in
vivo, will undoubtedly be crucial to the understanding of
several platelet processes such as shape change and filopodial
formation .
MATERIALS AND METHODS
Acrylamide, bis-acrylamide, N,N,N',N'-tetramethylenediamine (TEMED), and
glycine wereobtainedfrom Bio-Rad Laboratories, Inc. (Richmond, Calif). Triton
X-100 and PIPES were purchased from Calbiochem-Behring Corp. (LaJolla,
Calif.) . Leupeptin is a generous gift ofProfessorH . Umezawa ofthe Institute for
Microbial Chemistry, Tokyo, Japan. EDTA, EGTA, SDS, ATP, and phenyl-
methylsulfonyl fluoride (PMSF) are purchased from the Sigma Chemical Co .
(St . Louis, Mo.) . Polyethylene glycol 6000 (PEG-6000) is purchased from J . T.
Baker Chemical Co . (Phillipsburg, N.J .) and DEAE-Sephacel is obtained from
Pharmacia Fine Chemicals (Piscataway,N. J.).
Preparation of Platelets
Four units ofhuman platelet concentrates were received -3 h after the blood
wasdrawn at the GreaterNewYork Blood Center . The platelet-rich plasma was
centrifuged at 350g for 20 minutes to pellet any contaminating erythrocytes and
leukocytes andwas then spun at 1,000g to pellet the platelets . The platelets were
gently resuspended and washed twice by centrifugation in a solution containing
126 mM NaCI, 5 mM KCI, 0.3 mM EDTA, 10 mM NaP0,, pH 7.4 (platelet
wash) . All utensils used in the platelet preparation were plastic or siliconized glass
and all operations were carried out at 4°C.
Protein Purifications
Rabbit skeletal muscle actin were prepared according to the method of
Spudich and Watt (46) .
Platelet actin andABPwere prepared as described in the text.
Protein concentrations ofcolumn fractions were determined by using the Bio-
Rad Coomassie Blue dye binding assay with y-globulin as the standard . Alter-
natively, protein determinations were made by the method of Lowry et al . (25)
using bovine serum albumin as the standard.
SDS PAGE
Samples to be electrophoresed were precipitated with 10% cold TCA and
washed with acetone, if necessary (when precipitation is from Triton X-100 or
PEG containing solutions) . After neutralization withNH40H, the protein pellets
were resuspended in 1% SDS, 1% 2-mercaptoethanol, 25 mM Tris-sulfate, pH
6.7, 0.002% bromophenol blue, 10% glycerol (gel sample buffer) and boiled for
2min before applying to gel . The gels were5.5% acrylamide, 25mM Tris-glycine,
pH 8.3, and were electrophoresed at 3mA per gel in a running buffer of25 mM
Tris-glycine,pH 8.3 . The gels were stainedat70°C with 0.1% Coomassie Brilliant
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Blue in 30% propanol, 10% acetic acid, and were destained at 70°C in 7% acetic
acid.
Polyacrylamide gels were scanned in a Quik-Scan densitometer (Helena
Laboratories, Beaumont, Texas), the area under each peak being simultaneously
monitored by an automatic integrator .
Electron Microscopy
To view the platelet cytoskeleton, a drop of cold Triton solubilization buffer
(1% Triton X-100, 40mM KCI, 10 mM imidazole-chloride, 10 mM EGTA, 2
mM NaN,,, pH 7.0) was added to a glow-discharged Formvar-coated grid
followed by 1 ,ul of washed platelets resuspended 1 :1 in the platelet wash. After
a few minutes, the grid was washed with 40 mM KCI, 10 mM PIPES, l mM
EGTA, 2 mM NaN3 , pH 6.8 (buffer A) and then negatively stained with 1%
uranyl acetate .
Samples ofpurified platelet actin, ABP, or platelet actin followed by platelet
ABP (conditions given in legend) were applied to glow-discharged Formvar-
coatedgrids in bufferA . The grids were rinsed with buffer A and then negatively
stained with 1% uranyl acetate .
RESULTS
Isolation of the Platelet Cytoskeleton
When washed human platelets were boiled in 1% SDS, 2-
mercaptoethanol, and run on SDS polyacrylamide gels (Fig. 1,
gel TP) the most striking feature observed was the preponder-
ance of actin (42,500 mol wt) . By quantitative densitometry,
we previously determined (27) that actin makes up -30% of
the platelets' total protein . Another outstanding feature of this
cell is the high molecular weight triplet . The lower band of the
triplet is myosin heavy chain (subunit molecular weight,
200,000), the middle band (subunit molecular weight, 230,000)
is as yet unknown, and the uppermost band (subunit molecular
weight, 260,000) we named actin-binding protein (27) . It is
curious, and probably most significant, that actin and the
proteins that bind to it constitute one halfofthe platelets' total
protein (myosin = 12%, ABP = 8%) (27).
As washed platelets (resuspended 1 :1 in platelet wash) are
added to 10 vol of ice-cold I% Triton X-100, 40mM KCI, 10
mM imidazole-chloride, 10mM EGTA, 2mM NaN 3, pH 7.0
(Triton solubilization buffer), a flocculence appears immedi-
ately in the tube. This flocculent precipitate can be collected at
3,000 g (2 min) after settling for 12 min on ice. The Triton-
FIGURE 1
￿
5.5% SDS PAGE of the cytoskeleton isolation . Stoichio-
metric loads of total platelets (TP), Triton-soluble platelet supernate
after 3,000 g centrifugation (S), and Triton-X-100-insoluble cyto-
skeleton (C) .insoluble material is seen (Fig. 1, gel C) to be composed almost
exclusively of actin, ABP, and a 105,000-dalton protein. Gen-
erally, this pellet contains 60-80% of the platelets' actin, 70-
95% of the total ABP, and 90% of the 105,000-dalton protein .
Conversely, the resulting supernate (gel S) is severely depleted
of these three proteins . Various amounts of myosin may also
be included in this pellet.
When platelets are treated with the Triton solubilization
buffer directly on a carbon-coated grid, the results obtained are
as seen in Fig . 2 . Negative staining of the Triton-insoluble
material reveals a structure with the correct size and shape for
a resting platelet . In the absence of the membrane and the
Triton-soluble cytoplasmic components, it is easy to visualize
the branched bundles of filaments -0.1-0.2 ,u,m in diameter .
The individual filaments resemble actin microfilaments in their
dimensions . Microtubules are absent from this preparation,
probably because of their depolymerization in the cold and
subsequent solubilization by Triton.
Thus it appears that upon treatment with a Triton-EGTA
solution, most of the platelets' components are solubilized with
the exception of the platelet cytoskeleton-an easily sediment-
able structure consisting mainly of ABP, actin, and the 105,000-
dalton protein organized as microfilament bundles within the
cell.
All of the components of the cytoskeleton-isolation solution
are important . Omission of, or changes in the concentrations
of any of the components, or the addition of new components
can alter the composition or amount of the Triton-insoluble
material .
Inclusion of 10 mM EDTA in the cytoskeletal-isolation
solution would result in the formation of rigor bonds between
myosin and the actin filaments ofthe platelet cytoskeleton and,
consequently, more myosin would be included in the flocculent
precipitate. We named this structure the "contractile appara-
tus" (28) . Conversely, if MgATP had been added to the cyto-
skeleton isolation solution, the myosin seen here to be included
in the cytoskeletal precipitate would have been absent .
If the concentration of KCl in the isolation solution is
increased to >0 .1 M, the recovery of ABP in the cytoskeletal
complex is markedly reduced . This occurs because at higher
salt concentrations, ABP becomes solubilized from the cyto-
skeleton and begins appearing in the supernate, as will be seen
below .
The necessity for the high concentrations of EGTA in the
isolation solution has two reasons. First, platelets have been
shown to contain a Ca+2-activated, sulfhydryl-dependent, neu-
tral protease (41, 50) . This protease is activated at 0.17 mM
Ca+2 and has been shown to specifically attack ABP and the
230,000-dalton protein (50) . If EGTA is omitted from the
cytoskeleton isolation solution, the release of membrane-lim-
ited Ca` by Triton leads to the complete disappearance of
these two proteins within 10 min on ice (Fig. 3, gelA). However,
if platelets are diluted into increasingly larger volumes of the
Triton solution, the Ca" levels can be lowered enough to
prevent the proteolytic events (Fig. 3, gels B-G) . This effect is
indeed attributable to a decreased level of Ca
+2 and not to a
dilution-induced inactivation of the protease, because the ad-
dition of 1 mM CaC12 to the most dilute sample will result in
extensive proteolysis (not shown). The final [Ca"] in the
platelet dilution showing the onset ofproteolysis (Fig. 3, gel D)
should be 0.17 mM, thereby allowing us to back calculate the
[Ca+21 in the platelets to be -51 mM .
The second reason for the high EGTA requirement for
cytoskeletal isolation can be seen in Fig . 4 . In this set of
experiments platelets are added to Triton solubilization solu-
tions with and withoutEGTA but including 100 FLg/ml leupep-
tin, which is a potent inhibitor of the Ca+2-activated protease
(41) . It can be seen (gel E) that very little cytoskeleton can be
FIGURE 2
￿
Resting discoid platelet (resuspended 1 :1 in platelet wash) immersed in 10 vol of ice-cold Triton solubilization buffer
(1% Triton X-100, 40 mM KCI, 10 mM EGTA, 10 mM imidazole-chloride, 2mM NaN 3 , pH 7.0) washed with buffer A and negatively
stained with 1% uranyl acetate . Note the network of actin filament bundles comprising this Triton-X-100-insoluble platelet
remnant . Bar, 0.2Wm . X 62,500 .
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203FIGURE 3 5.5% SIDS PAGE of Ca'-dependent protease turn-on
point in platelet lysates . 10 Al of platelets (resuspended 1 :1 in
platelet wash) are added to (A) 0.1, (B) 0 .75, (C) 1 .0, (D) 1 .5, (E) 2 .0,
(F) 3 .0, and (G) 4.0 ml of Triton solubilization buffer without EGTA
(1% Triton X-100, 40 mM KCI, 10 mM imidazole-chloride, 2 mM
NaN3, pH 7.0) . After 12 min on ice, all samples are precipitated with
9 vol of cold acetone (1,000 g, 5 min) . Acetone pellets are then
brought to the same final volume in gel sample buffer and equal
loads are electrophoresed . Small arrows point to the bands that
disappear and large arrows point to those that appear upon prote-
olysis . Proteolysis is judged to begin in gel D by the appearance of
the 190,000-dalton breakdown product and the reduction in staining
of the 230,000-dalton protein . Therefore, if the [Ca+zj in this 1 .5-ml
sample is 0.17 mM (protease turn-on point), all of the Ca" having
been contributed by the 5 gl of platelets, the [Ca +21 within the
platelets is calculated to be 51 mM .
FIGURE 4
￿
5.5% SIDS PAGE of platelets added to the Triton solubil-
ization buffer in the presence and absence of EGTA . 25 gl of 1 :1
resuspended platelets are added to 250 tal of Triton solubilization
buffer containing 10 mM EGTA (gels A-D) or without any EGTA
(gels E-H) . All solutions have a final concentration of 100 fag/ml of
leupeptin to prevent proteolysis . Cytoskeletons are collected at
3,000 g (gels A and E) and the resulting supernates (gels B and F)
are recentrifuged in an airfuge (Beckman Instruments Inc ., West-
bury, N.Y .) at 148,000 g (20 min) . The high-speed pellets (gels C and
G) and supernates (gels D and H) are shown . All gel loads are
stoichiometric.
isolated in the absence ofEGTA as compared with that in the
presence of 10mM EGTA (gel A) even though no proteolysis
has occurred . Intact ABP remains in the low-speed supernate
after Triton immersion (gel F). Itmay be noteworthy, however,
that no 105,000-dalton protein is included in the small amount
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of cytoskeleton that is isolated in the presence of Ca+2 . The
105,000-dalton protein may only be able to bind to the ABP-
actin complex in the absence ofCa+2
.
Next, it was ofinterest to determine the state of the actin left
behind in the low-speed Triton supernate . Because free F-actin
filaments are soluble in 1% Triton (only cross-linked actin
filaments, as by ABP, are Triton insoluble; unpublished obser-
vation), high-speed centrifugation was necessary to differen-
tiate between F- and G-actin . It can be seen (Fig . 4, gels C and
G) that little if any of the Triton-soluble actin sediments at
148,000 g, demonstrating that it is not in the filamentous state.
Thus it appears that, in the presence of Ca", not only is the
cytoskeleton disrupted, but the uncomplexed actin is either
depolymerized or fragmented into small oligomers that do not
pellet at the speeds used. Alternatively, it may simply be that
free actin filaments (perhaps as in gel B, or after ABP has been
removed by a Ca'-directed event as in gel F) were more easily
depolymerized when diluted 20-fold into the Triton solubili-
zation solution .
Purification of ABP
The cytoskeleton isolated by the Triton-EGTA solubilization
is washed once in the Triton-EGTA buffer and then twice in
buffer A by resuspending and recentrifuging at 3,000 g for 2
min. The washed pellet is then resuspended in 0.6M KCI, 10
mM PIPES, 2mM NaNa, pH 6.8 (high-salt buffer), homoge-
nized for 2 min on ice, and clarified of high-salt-insoluble
proteins at 25,000 g for 15 min (Fig . 5) . Generally, the majority
of the protein is solubilized by this procedure . The high-salt-
soluble supernate is then brought to 5mM in EGTA-ATP and
stored for 16 h at 4°C. Kane (22) originally described the
phenomenon that sea urchin egg actin forms birefringent bun-
dles of filaments when ATP is added to a gelled extract
solubilized by high salt . We find this to be the case withhuman
platelet actin as well. When the high-salt/EGTA/ATP solution
is centrifuged at 25,000 g (15 min), the pellet is seen to consist
mostly of actin (Fig . 5, gel E), leaving the ABP behind in the
supernate. This "bundling" step thereby provides a mechanism
for easily separating actin from ABP once they are dissociated
from each other in high salt. The actin bundles are used for the
subsequent purification of actin while the bundle supernate is
used for the preparation of ABP. 500 /0 (wt/vol) PEG-6000 is
added to this ABP-rich supernate until a final concentration of
FIGURE 5 5.5% SDS PAGE of the initial ABP purification . Starting
cytoskeleton (A), 25,000 g supernate (B), and pellet (C) after solu-
bilization of the cytoskeleton in 0.6 M KCI . 25,000 g supernate (D)
and pellet (E) after the "bundling" of actin in the high-salt-soluble
fraction with EGTA-ATP . 10,000 g supernate (F) and pellet (G) after
the precipitation of the bundle supernate with 5% PEG and the 5%
PEG pellet resuspended and clarified (H) .5% is reached . After sitting for 10 min on ice, the solution is
centrifuged at 10,000 g (12 min), sedimenting the ABP and
separating it from most of its major contaminants (Fig. 5, gels
F and G) . The pellet is resuspended in buffer A minus KCI
and its subsequent clarification (25,000 g, 30 min) usually
removes the slight myosin contamination (Fig. 5, gel H) . This
PEG-purified ABP is generally found to be 90% pure when
subjected to quantitative densitometry.
PEG-purified ABP is then applied to a DEAE-Sephacel
column in 10mM PIPES, 1 mM EGTA, 2mM NaN3 , pH 6.8,
and the adherent proteins are eluted with a linear KCI gradient
(Fig. 6) . ABP is seen to be eluted at -0.2 M KCI, free of its
contaminating proteins . The ABP peak is pooled, concentrated
by dialysis against glycerol, and then dialyzed into buffer A .
The yield ofABP during the purification is presented in Table
I . The purified ABP can be stored for weeks in the refrigerator
in 1 mM PMSF without any evidence of proteolysis or loss of
its ability to bind to actin .
Purification of Platelet Actin
Two methods have been used to purify platelet actin . Actin-
rich bundles (generated during the ABP purification) are re-
suspended in 0.6M KCI, 10mM PIPES, 2mM NaN 3 , pH 6.8,
and rebundled overnight with 5mMEGTA-ATP (Fig . 7). This
process can be repeated several times, each time resulting in a
further purification ofthe actin. Finally, the actin bundles are
resuspended in buffer A, homogenized on ice, and centrifuged
at 15,000 g (15 min) to pellet any actin complexes. The resulting
supernate is seen to be highly purified actin.The pelleted actin
can be redissolved in buffer A and recentrifuged to increase
the yield of purified actin .
Alternatively, the actin-rich, high-salt-insoluble material
generated during the ABP purification (Fig. 5, gel C) can be
used to prepare actin . This pellet can be dissolved in and
dialyzed against actin depolymerization buffer (2 mM Tris-
HCI, 0.2 mM CaATP, 0 .5 mM 2-mercaptoethanol, pH 8.0) .
Actin is then purified through repeated cycles of polymeriza-
tion and depolymerization according to Spudich and Watt
(46) .
The highly purified platelet actin is seen to retain its ability
to self-associate into 25,000 g sedimentable bundles in 0.6 M
KCI, 5 mM EGTA-ATP (Fig. 8) . It is a unique observation
that a mammalian actin can be bundled . Bryan and Kane (9)
suggested that "actin bundling" is not a property common to
all actins, because they were not able to bundle vertebrate
skeletal muscle actin under identical conditions . We have
confirmed their observation on rabbit skeletal muscle actin,
which will not form bundles when treated in the same way as
the platelet actin . Platelet actin has a critical concentration for
bundling equal to 1 .1 mg/ml in 5 mM EGTA-ATP as com-
pared with sea urchin egg actin, which has a critical concentra-
tion for bundling of 1 .2-1.3 mg/ml in 1 mM ATP (9) .
The ability of the purified actin to bundle discounts the
possibility that a contaminant in the high-salt extracts of the
platelet cytoskeleton (e.g. the 105,000-dalton protein) was caus-
Recovery ofABPduring Purification
Purification Step
TABLE I
% ABP recovered
The ABP purification was carried out as described in the text. At each stage of
the purification, aliquots were removed and processed for SIDS PAGE. Stoi-
chiometric loads of the gel samples were electrophoresed, and the gels were
scanned for their protein content . The % ABP recovered was a measure of the
area under the ABPpeak at each step of the purification compared with that
in the total platelet . Results represent the average of five experiments .
FIGURE 6
￿
DEAE-Sephacel column purification of ABP. 3 mg of PEG-purified ABP are applied to a 0.7 x 5.0 cm DEAE-Sephacel
column equilibrated with 10 mM PIPES, 1 mM EGTA, 2 mM NaN3 , pH 6.8. The column is washed with 2-3 column vol of this
buffer and then eluted in 1-ml fractions with 30 ml of a 0-0.4 M KCI linear concentration gradient (prepared in PIPES-EGTA
buffer) . Protein concentrations are determined in every other fraction using the Bio-Rad dye binding assay . The dotted line
represents the salt concentrations across the gradient. The inset shows 5.5% SDS polyacrylamide gels of selected column fractions
and the starting material applied to the column (St) .
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Total platelet 100
Cytoskeleton 89
0.6 M KCI soluble cytoskeleton 62
Bundle supernate 57
5% PEG pellet 52
DEAE-Sephacel peak 36FIGURE 7 5.5% SDS PAGE of the platelet actin purification by
bundling . Actin bundles (A), a by-product of the ABP purification
(Fig . 5, gel E), are rebundled in 5 mM EGTA-ATP to yield a cleaner
actin preparation (B) and its resultant supernate (C) . These cleaner
bundles are again cycled to yield another pellet (D) and supernate
(E) . The third bundle pellet is resuspended in buffer A, homoge-
nized, and centrifuged at 15,000 g to yield a pellet (F) and a
supernate (G) of purified actin .
ing the bundling and that it was not a property intrinsic to the
actin itself .
Recombination of ABP and Actin In Vitro
When 25,000-g-clarified solutions of ABP and actin are
added back together, in vitro, a flocculence forms immediately
in the tube (Fig . 9). Upon agitation, the structure tightens and
pulls away from the sides of the tube, exposing the fibrous
nature of the network. No structures can be seen in the tubes
containing ABP alone or actin alone subjected to the same
treatment .
This filamentous structure can be sedimented at 5,000 g and
the resulting supernate and pellet analyzed on SDS polyacryl-
amide gels . When PEG-purified ABP is used (Fig . 10), the
minor contaminants associated with this starting material do
not appear in the reformed cytoskeletal complex, suggesting
that these proteins are not important in the reassociation
reaction . This clearing out of contaminants upon in vitro
formation of the cytoskeleton can be exploited as an alternative
means of purifying the ABP . The reformed cytoskeletal com-
plex is dissolved in 0.6 M KCI by soaking overnight and
drawing up and down in a plastic pipette tip . Care must be
taken to avoid losing protein by denaturation (because of
vigorous repipetting) or by its sticking to the walls of the test
tube or pipette tip . The solubilized ABP-actin complex is then
centrifuged at 148,000 g, pelleting the F-actin and leaving the
G-actin and ABP in the supernate (Fig . 10, gel E) . ABP is
separated from the G-actin by 5% PEG precipitation. A higher
load of the ABP sample (Fig. 10, gel I) shows it to be highly
purified .
The recombination experiment can also be followed by
electron microscopy (Fig . 11) . Negatively stained platelet actin
filaments have a typical 7 nm diameter and appear to be
randomly oriented . Negatively stained ABP appears as beaded
coils or donuts, as described by Stossel and Hartwig (48) . When
these two proteins are added together on an EM grid the result
is the alignment of the actin filaments into cables . Some free
actin filaments can be seen, but most of them are arranged in
parallel to form these thick cables. The supramolecular nature
of this structure accounts for the low-speed sedimentability
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(5,000 g) ofthe ABP-actin complex, formed from solutions that
had previously been clarified at 25,000 g.
Rabbit skeletal muscle actin and platelet actin will both
recombine with platelet ABP to form this cytoskeletal complex,
provided that the actin is in the filamentous form . However, if
G-actin (rabbit skeletalmuscle orhuman platelet) is substituted
for F-actin and if the combination with ABP is carried out in
depolymerization buffer, no low-speed sedimentable complex
will form . When G-actin is added to ABP in the presence of 2
mM MgCl2 , to induce the polymerization of the actin, the
cytoskeletal complex forms immediately in the tube (Fig. 12) .
Therefore, it appears that ABP can form the low-speed sedi-
mentable complex only with F-actin and not with G-actin .
When F-actin is used for the recombination, the cytoskeletal
complex reforms rapidly at all temperatures tested (4°-37°C) .
Recombination of the purified components also appears to be
independent of the presence or absence of divalent cations or
ATP (data not shown) . The Ca
+2 sensitivity ofthe cytoskeletal
assembly, which was present in the whole platelet, is lost upon
the purification of its components .
The recombination ofABP and F-actin is, however, affected
by the ionic strength of the solution in which recombination
takes place. It can be seen in Fig. 13, that as the KCI concen-
tration is increased, the amount of ABP pelleting in the cyto-
skeletal complex is decreased . Only after a significant amount
of the ABP is solubilized does the actin begin to appear in the
supemate as well. This is attributable to the ability of small
amounts ofABP to bind up large amounts of actin . This high-
salt solubility of the ABP-actin complex, seen here to result
from the removal of ABP from the actin filaments, has been
taken advantage of in the separation and purification of these
platelet proteins.
DISCUSSION
Isolation of the Cytoskeleton
We believe that the platelet cytoskeleton as revealed in Fig .
2 ties in the ectoplasmic region just beneath the cell membrane,
which excludes all platelet organelles . Morphological evidence
for the attachment of actin filaments to platelet plasma mem-
branes (58) and the presence of membrane contamination in
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FIGURE 8
￿
Actin bundling in high salt .Human platelet (open circles)
and rabbit skeletal muscle actin (closed circles) are prepared as
described in the text . Protein solutions are diluted to various starting
actin concentrations in equal volumes of 0 .6 M KCI and then EGTA-
ATP is added to a final concentration of 5 mM . After 16 h at 4°C,
the samples are centrifuged at 25,000 g for 15 min to pellet any
newly formed bundles . Bundle pellets are resuspended in equal
volumes of 0 .6 M KCI and Lowry (26) protein determinations are
performed on the bundle pellets and supernates as well as on the
original actin dilutions to determine the extent of bundle formation .FIGURE 9
￿
Recombination of ABP and F-actin, in vitro . In each panel, the first cuvette contains 0.8 ml of 3 .2 mg/ml ABP, (in buffer
A), the second cuvette has 1 ml of 1.84 mg/ml rabbit skeletal muscle F-actin (in 50 mM KCI, 2 MM MgC12 ) and the third cuvette
has a combination of the first two . Panel a is photographed at time 0 after the addition of actin to ABP in buffer A . Panels b, c, and
d are photographed 6, 8, and 10 min, respectively, after intermittent agitation of the tube .
crude platelet actomyosin preparations (40) suggest the close
proximity ofactin to the plasma membrane . Platelet membrane
fractions were shown to contain a large amount of F-actin,
which enhanced the MgATPase of muscle myosin by two- to
threefold (13). Perhaps actin filaments have not been seen in
the intact platelets' cortex by thin-section electron microscopy
because they are bundled as twisted strands in a rope and
therefore can never be in a proper plane of alignment to be
seen in fixed and sectioned material.
Triton solutions have been used in the isolation of cyto-
skeletons since their introduction in 1976 by Brown et al . (8) .
In platelets, we find the cytoskeleton to consist mainly of ABP,
actin, and 105,000-dalton protein (Fig . 1) . The quantitative
recovery of the 105,000-dalton protein from the platelet with
the Triton solubilization buffer suggests that it is associated
with the cytoskeleton in vivo even though it is not necessary
for the in vitro interaction of purified ABP and actin (Fig. 9
and 11) . Partially purified ABP and actin actually exclude the
105,000-dalton protein when forming the low-speed sediment-
able ABP-actin complex (Fig. 10) . We have achieved a partial
purification of this protein and find that it comigrates with a-
actinin on 5.5% SDS PAGE and cross-reacts with antibodies
to a-actinin . It is different from a-actinin, though, in that its
binding to actin appears to be Ca'-sensitive (S . Rosenberg, K.
Burridge, andA . Stracher, manuscript in preparation) . We can
only speculate on the role of the 105,000-dalton protein in the
platelet cytoskeleton . It may serve to link theABP cross-linked
actin filaments to sites beneath the plasma membrane, releasing
FicURE 10 5.5% SIDS PAGE of ABP and F-actin recombination, in
vitro . 1 .5 mg of PEG-purified ABP (A) is added to 0.83 mg of F-actin
(doubled load) (8) in buffer A + 2 MM M9CIZ . After 15 min at room
temperature, the solution is centrifuged at 5,000 g to yield a super-
nate (C) and a pellet (D) . Alternatively, the syneresed fluid can
simply be decanted off . The pellet is resuspended in 0 .6 M KCI, 10
mM PIPES, 2 mM NaN3 , pH 6 .8, stored overnight and then spun in
a Beckman airfuge at 148,000 g for 20 min to yield a supernate (E)
and a pellet (F) . The high-salt-soluble supernate is brought to 5% in
PEG and sedimented at 10,000 g to yield a supernate (G) and a
pellet (H) . A higher load of the pellet is also shown (1) .
them under conditions of Ca
+2 flux to allow for the redistri-
bution of the cytoskeletal components.
To preserve the cytoskeleton during the isolation procedure,
it is essential to keep the concentration of calcium low. This
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207FIGURE 11 Recombination of platelet actin and ABP, in vitro . (a) Platelet F-actin (0.3 mg/ml, in 50 mM KCI, 2 mM M9Cl2)
negatively stained with 1% uranyl acetate . Inset shows negatively stained ABP (note the absence of any filaments in this
preparation) with arrows pointing out donutlike structures . b and c show platelet F-actin combined with ABP in buffer A (ABP:
actin = 1 :10 by weight) on an EM grid, washed with buffer A and stained with 1% uranyl acetate. The addition of ABP to actin,
even at this low ratio, causes the normally random actin filaments to align themselves into cablelike structures. Bar, 0 .2 Jim . x
86,500 ; inset, x 112,100 .
FIGURE 12
￿
Recombination of ABP and G-actin, in vitro . 1 .0 ml of 0.8 mg/ml platelet G-actin (in depolymerization buffer) is added
to 1 .0 ml of 3 .0 mg/ml ABP in buffer A + 4mM M9Cl2. Panel a is photographed at time 0 after the addition of the G-actin . Panels
b, c, and d are photographed after intermittent agitation of the tube at 6, 8, and 10 min, respectively . Note how the structure in
panels a and b comes to a small peak at the top ; the actin began polymerizing and complexing with the ABP even before the
pipette adding it could be removed from the tube and, upon withdrawal of the pipette, this small piece was pulled up .
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FIGURE 13 Effect of ionic strength on the recombination of ABP
and actin, in vitro . 102 dag of skeletal muscle F-actin (final concen-
tration, 0.41 mg/ml) is added to 88 fig of platelet ABP in solutions
of increasing [KCI] (+ 10 mM PIPES, 0 .3 MM M9Cl2 , 0.12 mM EGTA,
pH 6 .8) . After 15 min at room temperature, the ABP-actin complex
is sedimented out at 5,000 g and the supernates are precipitated
with cold 10% TCA . Gel samples are prepared and stoichiometric
loads of the pellet and supernate are electrophoresed on SIDS
polyacrylamide gels . Gels are scanned in a Helena Quik-Scan den-
sitometer equipped with an automatic integrater . Percent ABP in
pellet (closed circles) and percent actin in pellet (open circles) are
plotted against the KCI concentration .
requires a high concentration ofEGTA, because the total free
[Ca"] within the platelet is determined from this study to be
51 mM (Fig. 3) . The accuracy of this figure, however, is
dependent upon the condition that the Ca'-activated protease
is turned on in the cell lysate at the same Ca" level that the
partially purified protease is turned on in vitro with "C-casein
as its substrate. The release of Ca" from the platelets' mem-
brane-enclosed dense bodies by the addition of Triton X-100
leads to the rapid breakdown (<10 min at 4°C) of ABP and
the 230,000-dalton protein . At higher [Ca"] (Fig. 3, gel A), an
80,000 mol wt polypeptide begins to disappear . ABP prote-
olysis, however, is not the only reason for preventing the rise
in free Ca
+2 upon cell lysis . As can be seen in Fig . 4, evenwhen
the proteolysis is inhibited by the inclusion of leupeptin in the
Triton solubilization solution, no cytoskeletal complex can be
isolated in the absence of 10mM EGTA . This is not surprising,
though, because in cell-free extracts prepared from other cell
types (11, 12, 21, 22, 31, 43, 48, 55), the addition of micromolar
concentrations of calcium prevents the formation of actin gels
by actin-binding proteins upon warming of the extracts . The
Ca
+2 must be exerting its effect indirectly on the ABP-actin
cytoskeleton, perhaps through some other enzyme system in
the platelet, because purified ABP and actin can reform the
cytoskeletal network, in vitro, in the presence of millimolar
calcium . The Ca" sensitivity of this process in vivo, and its
loss upon the purification of the components, is not an unprec-
edented phenomenon (7, 9, 31, 32) .
Platelets serve as an excellent source for the preparation of
ABP and actin because they contain large quantities of these
two proteins. The key factors responsible for the high yields
and purity of these preparations are (a) a near-quantitative
recovery of ABP and actin in the first step (cytoskeletal isola-
tion), (b) the solubility of the ABP-actin complex in high salt,
and (c) the ability to bundle out the actin with EGTA-ATP,
thus separating it from the ABP (Fig . 5) . Because platelet actin
is found to have a critical concentration for bundling of 1 .1
mg/ml (Fig. 8) the ABP-actin complex is resuspended in only
a small volume ofhigh-salt buffer, one to two times the volume
of the original packed platelets, to keep the actin concentrated
enough to bundle. The repeated bundling steps (Fig. 7) clear
out the 105,000-dalton protein contaminant, which does not
seem to bind well to the actin in high salt .
We have also introduced precipitation with PEG-6000 to the
ABP purification. This may be responsible for enabling us to
store the ABP for weeks in the refrigerator, in low salt, without
encountering the extensive aggregation problem seen in some
filamin preparations (45, 53) using ammonium sulfate fraction-
ation . Also, because PEG fractionates essentially on the basis
of molecular weight (20), we avoided the use of gel filtration
chromatography. Care must be taken to exclude any F-actin
from the sample to be PEG fractionated (because ofincomplete
bundling in the prior step), because its presence leads to
irreversible clumping of the PEG precipitate .
The ability of partially purified ABP to rebind to actin and
exclude its associated contaminants can be used as a type of
biological affinity column for the further purification of the
ABP (Fig . 10) . The higher the ratio of ABP/actin used, the
better the cleaning step . One problem encountered here, how-
ever, is that in order to squeeze the maximum amount of
contaminants out of the reforming ABP-actin complex it is
necessary to form a tight structure (either by tapping on the
tube or by centrifugation) . A tighter structure is more difficult
to dissolve in the high-salt buffer and usually requires overnight
soaking and gentle resuspension . Alternatively, the PEG-puri-
fled ABP is separated from its contaminants on a DEAE-
Sephacel column (Fig . 6) .
Recombination of ABP and Actin In Vitro
The re-formation of the cytoskeletal complex in vitro from
purified components, occurs immediately on ice or at room
temperature. At the molecular level, it is seen as the organiza-
tion of random actin filaments into a more ordered network
(Fig . 11) . It is easy to imagine how this alignment of actin
filaments can account for the platelets' cytoskeletal structure
depicted in Fig . 2. At the gross morphological level, recombi-
nation ofABP and actin again shows an intricate meshwork of
fibers (Figs. 9 and 12) . The complexity of the structure formed
is easily discerned with the unaided eye . No cations, chelators,
nucleotides, or accessory proteins are necessary for the reassem-
bly of this cytoskeleton in vitro . Only buffered KCI is present
to keep the actin filamentous, since under actin-depolymerizing
conditions the cytoskeleton does not reform . However, as the
concentration ofKCI is increased, the ABP-actin interaction is
disrupted and the amount ofsedimentable ABP-actin complex
decreases (Fig. 13) .
Recombination experiments are generally performed at high
ratios of ABP/actin, because the effect of various factors on
the binding of ABP to F-actin can be more easily discerned
when working near the maximum binding ratio (1 .3-1.4/1,
ABP/actin by weight; S . Rosenberg and A. Stracher, manu-
script in preparation) . However, it is seen that even when only
small amounts ofABP participate in the recombination reac-
tion (e.g ., at increasing [KCI], Fig. 13), large amounts of actin
are still included in the low-speed sedimentable ABP-actin
complex that forms . There is enough ABP in the platelet to
account for the enlistment of all of the platelets' actin into the
cytoskeletal structure .
RosENBERG ET AL .
￿
Actin and Actin-binding Protein in Human Platelets
￿
209Role of ABP and Actin in Platelet Activation
Newly formed filopodia of activated platelets are found to
be replete with actin filaments aligned in parallel (57). Deco-
ration withHMM subfragment 1 reveals that all of the actin
filaments in the filopodia are of the same polarity, with arrow-
heads pointing in towards the body of the platelet (35) . How
do these filopodiaform after the platelets are stimulated?What
regulates the movement of actin into these structures?
Filopodia are thought to form by either one of two mecha-
nisms: (a) polymerization ofcytoplasmic G-actin into filaments
pushingoutthe filopodia, or (b) from preformed actin filaments
that move out from the body of the platelet . Because we find
the majority of the platelets' actin to be in the filamentous
form, associated with ABP in the cytoskeleton (Fig. 1), we
propose that the latter mechanism occurs .
These results differ from those of others who find the ma-
jority of the platelets' actin to be in a nonfilamentous form (10,
34, 42) . The differences in our finding must lie in the Triton
solubilization solutions that we use . Our solution has a higher
EGTA concentration designed to chelatethe calculated 51 mM
Ca" in platelets, lower ionic strength, and lower pH, and the
solubilization is performed at a lower temperature . We have
shown that high ionic strength (Fig. 13) and Ca
+2 (Fig . 4) will
disrupt the formation of the cytoskeleton, and Carlsson et al.
(10) have also described a Ca"-induced depolymerization of
the platelets' actin. Therefore, it is possible that the differences
in ourTriton solutionsareenough to account forthe differences
in results . If anything, our Triton solutions' low ionic strength
and temperature and lack of divalent cations would cause the
depolymerization of actin-not its polymerization .
Platelet activation may occur in a fashion analogous to
coelomocyte transformation from petaloid to filopodial cells.
These cells, described by Edds (15, 16), function as platelets in
the sea urchin where they send out filopodia and retract clots
to plug wounds. Actin filaments, which are randomly oriented
in the petaloid (resting) cell, are repositioned upon activation
into a radial orientation. Bundles of filaments form and these
go on to form larger bundles that eventually become the axial
support for each filopodium .
The disassembly of the platelet cytoskeleton to allow for the
reorganization of actin filaments, and its reassembly after
filopodial formation, can all be under the controlofmicromolar
levels of intracellular Ca+2 . Nachmias (36, 37) has shown that
filopodial formation can be arrested when platelets are treated
with local anesthetics. Concomitant with the irreversible sup-
pression of filopodial formation is the proteolysis of ABP .
Because local anesthetics displace Ca" from cell membranes
(18, 24), shesuggested that the activation oftheCa+2-dependent
protease could be responsible for the degradation of the ABP .
We have shown that the heavy fragment of proteolyzed ABP
(HF-1, ABP molecular weight = 190,000) can bind to but not
cross-link actin filaments (51). Therefore, her data provide
excellent evidence that intact, functional ABP is an absolute
requirement for filopodial formation . Using lower concentra-
tions of anesthetics, however, Nachmias observed no ABP
proteolysis, and the filopodial suppression could be reversed
by washing out the anesthetic (36, 37) . Perhaps at the lower
anesthetic concentrations, less Ca" was displaced so that the
free calcium level within the platelet still rose but not to the
level necessary to cause proteolysis . As we have shown in Fig .
4, the cytoskeleton is disrupted under conditions of increased
[Ca"] in the absence of proteolysis . Nicholson et al . (38, 39)
presented morphological evidence that local anesthetics cause
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dramatic changes in cell shape and cytoskeeeool organization .
They proposed Ca" displacement from the membrane as the
cause of membrane blebbing and a destabilization of the
microfilaments beneath theplasma membrane, uncoupling any
cooperation between them (38) .
Therefore, ABP appears to play a crucial role in filopodial
formation in relation to its association with or dissociation
from actin . We postulate that the state of assembly of these
two proteins can be controlled by calcium fluxes in the platelet
in vivo, i.e ., during platelet activaton .
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